Published:  Feb 27, 2013DOI: 10.7324/JAPS.2013.30215
A stability indicating analytical method has been developed and validated. In this study Hydrochlorothiazide was degraded under different stress test conditions as per International Conference on Harmonization. The degraded samples were used to develop a stability-indicating high performance liquid chromatographic (HPLC) method for the Hydrochlorothiazide. The Hydrochlorothiazide was well separated from degradation products using a reversed-phase (C-18) column and a mobile phase comprising of Methanol: Buffer pH- 3.2 (60:40 v/v) and other HPLC parameters were flow rate 1 mL/min, detection wavelength 270 nm and injection volume 20 µl. The method was validated for linearity, precision, accuracy, ruggedness and robustness. Results obtained after validation study indicating that the proposed single method allowed analysis of Hydrochlorothiazide in the presence of their degradation products formed under a variety of stress conditions. The developed procedure was also applicable to the determination of stability of the Hydrochlorothiazide in commercial pharmaceutical dosage form.
Sachin Bhagwate and N. J. Gaikwad., Stability Indicating hplc Method for the Determination of Hydrochlorothiazide in Pharmaceutical Dosage form. J App Pharm Sci. 2013; 3 (02): 088- 092.
670 Absract views 9 PDF Downloads 679 Total views
Spectrophotometric Simultaneous Determination of Hydrochlorothiazide and Telmisartan in Combined Dosage FormRekha Gangola, Sunil Kaushik, Paras Sharma
A validated stability indicating HPLC method for the determination of Valsartan in tablet dosage forms
Development and validation of dissolution proceduresBhavesh Vaghela, Rajan Kayastha, Nayana Bhatt, Nimish Pathak, Dashrath Rathod
Formulation and evaluation of Salbutamol sulphate microspheres by solvent evaporation methodV.V Prasanth, Akashmoy Chakraborty, Sam T Mathew, Rinku Mathappan, V. Kamalakkannan
Stability Indicating Method for the Determination of Mefenamic Acid in Pharmaceutical Formulations by HPLC